Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor vs Ticagrelor in AMI with Cardiogenic Shock
NCT03551964Phase 4Completed
- Sponsor
- Faculty Hospital Kralovske Vinohrady
- Start
- Aug 2018
- Primary completion
- Feb 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 4 trial of cangrelor in acute myocardial infarction (AMI), cardiogenic shock, sponsored by Faculty Hospital Kralovske Vinohrady. Started Aug 2018; status: completed.
02
Drugs
cangrelor
03
Conditions
acute myocardial infarction (AMI)cardiogenic shock
Beyond the preview
Go deeper on NCT03551964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03551964.